Xpeng G9L Passes Trial Build at Magna's Graz Plant, Orders Set to Open in Paris

Xpeng has cleared another hurdle in its European expansion, with its G9L SUV completing a trial production run at Magna Steyr’s Graz facility in Austria. The milestone makes the G9L the fourth model the Chinese automaker builds on European soil, following the G6, G9 and P7+ onto the same line.
A pre-production example of the G9L will now make a 1,324 km drive to Paris, where customer orders are scheduled to open on 12 October, timed to the model’s premiere at the Paris Motor Show. Assembly at Graz began in the third quarter of 2025 as Xpeng’s first European manufacturing programme, and the addition of a fourth nameplate within roughly a year underlines how quickly the arrangement is scaling up.
The numbers behind that push are growing steadily. Xpeng has delivered more than 100,000 vehicles outside China, with over 60,000 of those finding homes in Europe. Overseas deliveries topped 20,000 units in a single quarter for the first time between April and June 2026, an 81% increase year on year. International markets accounted for a quarter of the company’s first-half revenue, with average selling prices above €40,000 (about US$44,800).
The G9L is planned for sale across 64 countries and regions. Xpeng says the model has accumulated 6.74 million kilometres of testing across 26 markets over three years, a programme that included 192 crash tests. Chassis hardware on the standard car combines dual-chamber air suspension and variable damping with rear-wheel steering capable of turning up to 15 degrees.
Zhang Li, Vice President of Global Manufacturing at Xpeng, framed the trial build as a turning point: “The latest production milestone represents an important step in our journey from entering Europe to building for Europe. By combining global vehicle development and AI technology with established local manufacturing expertise, we are bringing the next-gen Xpeng vehicles closer to customers in Europe and around the world.” The arrangement also hands Magna’s contract manufacturing business fresh relevance at a time when established volume assumptions across the industry are shifting.
What do you think?